
University of Chieti, Italy;
Dr. Barbara De Filippis has a degree in Pharmaceutical Chemistry and Technology and earned her PhD in Medicinal Chemistry Sciences at the University of Chieti (Italy), where she is currently an Assistant Professor of Medicinal Chemistry. Her main expertise deals with the design and synthesis of stilbene derivatives with multiple pharmacological potential. Over the past several years, the principal interest of Dr. De Filippis’ research group was related to the studies of PPARs involved in metabolic diseases [e.g., B. De Filippis et al., Structural development studies of PPARs ligands based on tyrosine scaffold, European Journal of Medicinal Chemistry, 89, 817-825, 2015; B. De Filippis et al., In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on C2C12 and MCF7 cells. J Biol Regul Homeost Agents 31(3), 589-601, 2017] and the synthesis of fibrate derivatives with different isoform selectivity. Her current research interests have shifted toward the design and the synthesis of natural polyphenol derivatives, in particular resveratrol and caffeic acid, with their anticancer, antioxidant and antimicrobial biological activities, among others [e.g., B. De Filippis et al., Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs. Medicinal Chemistry Research 28, 984-991, 2019; B. De Filippis et al., Synthesis and Biological Evaluation of Halogenated E-Stilbenols as Promising Antiaging Agents. Molecules 2020, 25, 5770; B. De Filippis et al., Searching for new tools to counteract the Helicobacter pylori resistance: the positive action of resveratrol derivatives. Antibiotics, 2020 9, 891]. She has co-authored more than 60 scientific articles.
Synthesis and Identification of Small Compounds Active in Neurodegeneration in Molecules
Synthesis and Identification of Small Compounds Active in Neurodegeneration in Chemistry
Guest Editor: Dr. Barbara De Filippis
Co-Guest Editor: Prof. Dr. Gunter P. Eckert
Deadline for manuscript submissions: 30 September 2021